Created at	Source	Raw Value	Validated value
Dec. 3, 2021, 11:30 p.m.	usa	Geometric Mean Titers for Serum Neutralizing Antibodies as Measured by Plaque Reduction Neutralization Test;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event;Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Unsolicited Adverse Event	Geometric Mean Titers for Serum Neutralizing Antibodies as Measured by Plaque Reduction Neutralization Test;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event;Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Unsolicited Adverse Event
Oct. 26, 2020, 11:31 p.m.	usa	Percentage of Participants with at Least 1 Unsolicited Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event;Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Geometric Mean Titers for Serum Neutralizing Antibodies as Measured by Plaque Reduction Neutralization Test (Panels A - H)	Percentage of Participants with at Least 1 Unsolicited Adverse Event;Percentage of Participants with at Least 1 Solicited Injection Site Adverse Event;Percentage of Participants with at Least 1 Solicited Systemic Adverse Event;Percentage of Participants with at Least 1 Medically Attended Adverse Event;Percentage of Participants with at Least 1 Serious Adverse Event;Geometric Mean Titers for Serum Neutralizing Antibodies as Measured by Plaque Reduction Neutralization Test (Panels A - H)